A naturally occurring gamma globin gene mutation enhances SP1 binding activity

Area of Science:

• Genetics
• Molecular Biology
• Hematology

Background:

• Human fetal globin gene expression is tightly regulated during development.
• Mutations upstream of gamma globin genes can disrupt this regulation, causing elevated fetal globin synthesis in adults.

Purpose of the Study:

• To investigate the molecular mechanisms behind two specific mutations (-202 C-to-G and -202 C-to-T) affecting human gamma globin gene expression.
• To determine how these mutations impact nuclear protein binding and correlate with hereditary persistence of fetal hemoglobin.

Main Methods:

• Analysis of DNA sequences and their similarity to Sp1 recognition sites.
• In vitro studies to assess the binding affinity of nuclear proteins (like Sp1) to mutated and normal gamma globin gene sequences.
• Correlation of observed binding changes with clinical data from patients with hereditary persistence of fetal hemoglobin.

Main Results:

• A C-to-G mutation at -202 significantly increased Sp1 binding affinity and gene expression, while reducing normal factor binding.
• A C-to-T mutation at -202 decreased similarity to Sp1 sites, did not enhance Sp1 binding, but altered normal factor binding, leading to moderate increases in fetal globin expression.
• These in vitro binding changes correlate with enhanced gamma globin gene expression in patients.

Conclusions:

• Changes in nuclear protein-binding properties due to specific upstream mutations are responsible for the enhanced gamma globin gene expression observed in hereditary persistence of fetal hemoglobin.
• The study elucidates the molecular basis for dysregulated fetal globin gene expression in certain genetic conditions.